Integrated Investment Consultants LLC Sells 39,820 Shares of Aflac Incorporated (NYSE:AFL)

Key Points

• Integrated Investment Consultants LLC reduced its stake in Aflac Incorporated by 95.6%, selling 39,820 shares and now holding only 1,848 shares worth $205,000.
• Insider trading saw multiple Aflac directors selling a substantial number of shares, with a combined 40,750 shares sold recently, reflecting a decrease in ownership among insiders.
• Aflac's recent earnings report showed a decline in revenue, with EPS of $1.66, missing consensus estimates, and revenue down 37.5% from the previous year.

Integrated Investment Consultants LLC reduced its position in Aflac Incorporated (NYSE:AFL - Free Report) by 95.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,848 shares of the financial services provider's stock after selling 39,820 shares during the period. Integrated Investment Consultants LLC's holdings in Aflac were worth $205,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in Aflac during the fourth quarter worth about $349,699,000. GAMMA Investing LLC raised its stake in Aflac by 12,313.9% during the first quarter. GAMMA Investing LLC now owns 1,504,067 shares of the financial services provider's stock worth $167,237,000 after acquiring an additional 1,491,951 shares during the period. Northern Trust Corp raised its stake in Aflac by 22.9% during the fourth quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock worth $754,700,000 after acquiring an additional 1,357,753 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Aflac by 11.9% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock worth $543,154,000 after acquiring an additional 556,394 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Aflac during the fourth quarter worth about $48,081,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aflac

In related news, Director Masatoshi Koide sold 37,000 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director owned 70,992 shares in the company, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the sale, the director owned 6,728 shares of the company's stock, valued at approximately $711,149.60. This trade represents a 29.01% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,750 shares of company stock worth $4,304,295. 0.80% of the stock is owned by corporate insiders.

Aflac Price Performance

NYSE:AFL traded down $1.20 during trading hours on Wednesday, reaching $99.63. 627,575 shares of the company's stock were exchanged, compared to its average volume of 2,109,491. The company has a market capitalization of $53.86 billion, a P/E ratio of 15.57, a price-to-earnings-growth ratio of 3.12 and a beta of 0.81. Aflac Incorporated has a 12 month low of $94.87 and a 12 month high of $115.50. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29. The business's 50-day simple moving average is $102.83 and its two-hundred day simple moving average is $105.16.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm's revenue was down 37.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.66 EPS. Sell-side analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on AFL shares. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. JPMorgan Chase & Co. upped their target price on shares of Aflac from $96.00 to $100.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 8th. UBS Group upped their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Morgan Stanley upped their target price on shares of Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research report on Wednesday, May 7th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $108.15.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.